Bayer Finds Partial Pharma Partner In Aventis Blood Products Joint Venture

Bayer/Aventis Behring's blood products joint venture would partly accomplish Bayer's goal of finding a strategic partner for its pharmaceutical business

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet